To include your compound in the COVID-19 Resource Center, submit it here.

FDA panel backs Memantine

An FDA advisory committee voted unanimously that Forest Laboratories (FRX) has demonstrated the safety and effectiveness of Memantine to treat moderate to severe Alzheimer's disease (AD). Committee members

Read the full 282 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE